- Home
- APGE vs CENX Comparison
APGE vs CENX Comparison
Compare APGE & CENX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APGE
- CENX
- Stock Information
- Founded
- APGE 2022
- CENX 1995
- Country
- APGE United States
- CENX United States
- Employees
- APGE N/A
- CENX N/A
- Industry
- APGE Biotechnology: Biological Products (No Diagnostic Substances)
- CENX Aluminum
- Sector
- APGE Health Care
- CENX Industrials
- Exchange
- APGE Nasdaq
- CENX Nasdaq
- Market Cap
- APGE 2.1B
- CENX 1.5B
- IPO Year
- APGE 2023
- CENX 1996
- Fundamental
- Price
- APGE $37.81
- CENX $15.51
- Analyst Decision
- APGE Strong Buy
- CENX Strong Buy
- Analyst Count
- APGE 4
- CENX 3
- Target Price
- APGE $91.33
- CENX $23.00
- AVG Volume (30 Days)
- APGE 579.0K
- CENX 1.5M
- Earning Date
- APGE 05-20-2025
- CENX 05-07-2025
- Dividend Yield
- APGE N/A
- CENX N/A
- EPS Growth
- APGE N/A
- CENX 35.22
- EPS
- APGE N/A
- CENX 3.12
- Revenue
- APGE N/A
- CENX $2,223,300,000.00
- Revenue This Year
- APGE N/A
- CENX $6.79
- Revenue Next Year
- APGE $743.14
- CENX $3.58
- P/E Ratio
- APGE N/A
- CENX $5.05
- Revenue Growth
- APGE N/A
- CENX 4.75
- 52 Week Low
- APGE $26.20
- CENX $11.40
- 52 Week High
- APGE $63.50
- CENX $25.39
- Technical
- Relative Strength Index (RSI)
- APGE 53.99
- CENX 41.68
- Support Level
- APGE $36.59
- CENX $15.71
- Resistance Level
- APGE $41.05
- CENX $17.57
- Average True Range (ATR)
- APGE 2.25
- CENX 0.79
- MACD
- APGE 0.15
- CENX 0.03
- Stochastic Oscillator
- APGE 62.72
- CENX 26.33
About APGE Apogee Therapeutics Inc.
Apogee Therapeutics Inc is a biotechnology company seeking to develop differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology (I&I) indications with high unmet need. Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.
About CENX Century Aluminum Company
Century Aluminum Co produces primary aluminum standard grade and value-added products. The firm operates smelter facilities in the United States and Iceland. The majority of revenue is generated from Glencore, which agreed to purchase nearly all of Century Aluminum's North American production. Century purchases nearly all of its alumina from Glencore. The company produces high purity aluminum, standard-grade aluminum sow and tee bars, and value-added billet and foundry products. Century also owns a carbon anode production facility in the Netherlands.